Medtronic Loses Appeal in $74 Million Edwards Patent Case

Medtronic Inc. lost its bid to overturn a $74 million jury verdict won by Edwards Lifesciences Corp. and may face a court order halting production of some of its CoreValve heart valves.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.